Metastatic Castrate-resistant Prostate (CRPC) Cancer
Oncology·MeSH: Neoplasms
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| ODM-201 | KYNTRA BIO INC. (KYNB) |
Frequently asked questions
How many drugs are in development for Metastatic Castrate-resistant Prostate (CRPC) Cancer?
BioSniper tracks 1 drug in development for Metastatic Castrate-resistant Prostate (CRPC) Cancer across 1 company.
How many clinical trials target Metastatic Castrate-resistant Prostate (CRPC) Cancer?
There are 1 clinical trial targeting Metastatic Castrate-resistant Prostate (CRPC) Cancer tracked by BioSniper.
Deep-dive into Metastatic Castrate-resistant Prostate (CRPC) Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis